Press conference to announce preventive effects of plant (konjac-derived) ceramides against Alzheimer’s amyloid pathologies

Academia-Industry Collaboration Unit (Lipid Biofunction Section) researchers, Kohei Yuyama and Yasuyuki Igarashi, have press conference (19 December 2019, Nihonbashi Life Science Building) to announce their recent findings that oral administration of plant (konjac-derived) ceramides attenuates Alzheimer’s disease-like pathologies.